Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2001-06-15
2010-10-19
Fay, Zohreh A (Department: 1612)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S626000
Reexamination Certificate
active
07816407
ABSTRACT:
Pharmaceutical preparations containing of agmatine, congeners, analogs or derivatives thereof for use in preventing or treating epilepsy, seizures and other electroconvulsive disorders are provided. Embodiments include administering an effective amount of agmatine, an agmatine analog or a pharmaceutically acceptable salt thereof to a human subject in need of treatment or prevention of epilepsy, seizure or other electroconvulsive disorder to treat, reduce, or prevent the disorder in the subject.
REFERENCES:
patent: 4134918 (1979-01-01), Bey et al.
patent: 4139563 (1979-02-01), Metcalf et al.
patent: 4267374 (1981-05-01), Metcalf et al.
patent: 4323704 (1982-04-01), Metcalf et al.
patent: 5432202 (1995-07-01), Cherksey et al.
patent: 5633230 (1997-05-01), Twist et al.
patent: 5677349 (1997-10-01), Gilad et al.
patent: 6150419 (2000-11-01), Fairbanks et al.
patent: 6297281 (2001-10-01), Chabrier de Lassauniere et al.
patent: 6441156 (2002-08-01), Lerman et al.
patent: WO98/09653 (1998-03-01), None
Rajasekaran et al, Effect of acute and repeated administration of nitric oxide . . . , 6th internet world congress for Biomedical science, 2000, see p. 3.
Seeley et al, Histamine H2-receptor modulation in two mouse models of seizure . . . , Inflammation Research (1999), vol. 48(Supp.1), pp. S67-S68.
Wada et al., Effects of the 5-HT3 receptor agonist . . . , Brain Research , 1997, vol. 759, pp. 313-316.
Uzbay et al., Effect of agmatine on ethanol withdrawal . . . , Behavioural Brain Research, 2000, vol. 107, pp. 153-159.
Rajasekaran et al., Effect of acute and repeated administration of NO . . . , 6th internet World congress for biomedical science(poster 129), 2000.
The Merck Index, Merck Research Laboratories Division of Merck & Co., Inc. 1996, p. 35.
James O. McNamara, “Drugs Effective in Therapy of the Epilepsies”, Goodman & Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition, Chapter 20, pp. 461-486, 1996.
I. Tayfun Uzbay et al., “Effects of agmatine on ethanol withdrawal syndrome in rats”, Behavioural Brain Research 107, (2000), pp. 153-159.
O. Carter Snead III, “Pharmacologlcal models of generalized absence seizures in rodents”, J. Neural Transm (1992) [Suppl], 35, pp. 1-19.
Gen Li et al., “Agmatine: An Endogenous Clonidine-Displacing Substance in the Brain”, vol. 263, Feb. 18, 1994, pp. 966-969.
Mark J. Lortie et al., “Agmatine, a Bioactive Metabolite of Aginine”, The American Society for Clinical Investigation, Inc., vol. 97, No. 2, Jan. 1996, pp. 413-420.
Jeremiah Morrissey et al., “Partial cloning and characterization of an arginine decarboxylase in the kidney”, Kidney International, vol. 47, (1995) pp. 1458-1461.
Magdalena Sastre et al., “Metabolism of agmatine in macrophages: modulation by lipopolysaccharide and inhibitory cytokines”, Biochem. J. (1999) 330, pp. 1405-1409.
S. Regunathan et al., “Imidazoline Receptors and Agmatine in Blood Vessels: A Novel System Inhibiting Vascular Smooth Muscle Proliferation”, The Journal of Pharmacology and Experimental Therapeutics, vol. 276, pp. 1272-1276, 1996.
S. Regunathan et al., “Agmatine(decarboxylated arginine)is sysnthesized and stored in astrocytes”, Rapid Science Publishers, vol. 6, No. 14, Oct. 2, 1995, pp. 1897-1900.
Nabil Anis et al., Structure-Activity Relationships of Philanthotoxin Analogs and Polyamines on N-Methyl-D-Aspartate and Nicotinic Acetylcholin Receptors, The Journal of Pharmacology and Experimental Therapeutics, vol. 254, pp. 764-771, 1990.
D.J. Reis et al., “Agmatine: a Novel Neurotransmitter?”, Advances in Pharmacology, vol. 42, pp. 645-649, 1998.
D.J. Reis et al., “Agmatine: and endoenous ligand at imidazoline receptors may be a novel neurotransmitter in brain”, Journal of the Autonomic Nervous System 72 (1998) pp. 80-85.
Joseph Satriano et al., “Agmatine Suppresses Proliferation by Frameshift Induction of Antizyme and Attenuation of Cellular Polyamine Levels”, LThe Journal of Biological Chemistry, vol. 273, No. 25, 1998, pp. 15313-15316.
Elena Galea et al., “Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine”, Biochem. J. (1998) 316, pp. 247-249.
James F. Kerwin, Jr. et al., “Nitric Oxide: A new Paradigm for Second Messengers”, Journal of Medicinal Chemistry, vol. 38, No. 22, pp. 4344-4362, 1995.
John MacMicking et al., “Nitric Oxide and Macrophage Function”, Annual Reviews Inc. 1997, 15, pp. 323-350.
Dennis J. Stuehr, Structure-Function Aspects in the Nitric Oxide Synthases, Annual Reviews Inc., 1997, 37, pp. 339-359.
Rene H. Levy, Ph.D. et al., “Antiepileptic Drugs”, Third Edition, Raven Press Ltd., 1989, pp. 85-102.
Rene H. Levy et al., “Antiepileptic Drugs”, Fourth Edition, Raven Press Ltd., 1995, pp. 91-97.
H. Steve White et al., “Experimental Selection, Quantification, and Evaluation of Antiepileptic Drugs”, Fourth Edition, Raven Press Ltd , 1995, pp. 99-110.
White H.S. et al., “The early identification of anticonvulsant activity: role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models”, The Italian Journal of Neurological Sciences, 16, 1995, pp. 73-77.
N.W. Dunham et al, “A Note on a Simple Apparatus for Detecting Neurological Deficit in Rats and Mice”, Journal of American Pharmaceutical Association, vol. XLVI, No. 3, Mar. 1957, pp. 208-209.
Bence Aimee K.
Crooks Peter A.
Worthen David R.
Fay Zohreh A
McDermott Will & Emery LLP
University of Kentucky Research Foundation
LandOfFree
Agmatine and agmatine analogs in the treatment of epilepsy,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agmatine and agmatine analogs in the treatment of epilepsy,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agmatine and agmatine analogs in the treatment of epilepsy,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4235551